Klinisk Neurofysiologi Uppsala

Main Content


Anna Rostedt Punga, MD, PhD, Associate Professor


Publikationer 2015-2018

  1. Sabre L, Maddison P, Wong S H, Sadalage G, Ambrose PA, Plant GT, Punga AR. MiR-30e-5p as predictor of generalization in ocular myasthenia gravis. Ann Clin Trans Neurol, in press.
  2. O´Connor L, Westerberg E, Punga AR. Pattern of habitual physical exercise in myasthenia gravis patients. J Neuromusc Dis, 2018 Nov 12. doi: 10.3233/JND-180355.
  3. Lewandowska MK, Bogatikov E, Hierlemann AR, Punga AR. Long-term high-density extracellular recordings enable studies of muscle cell physiology. Frontiers in Physiology, 2018 Oct 9;9:1424. doi: 10.3389/fphys.2018.01424. eCollection 2018 Publication link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6190753/
  4. Westerberg E, Landtblom AM, Punga AR. Life-style factors and disease-specific differences in subgroups of Swedish Myasthenia Gravis. Acta Neurol Scand. 2018 2018 Dec;138(6):557-565. Publication link:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6123855/
  5. Westerberg E, Molin CJ, Spörndly Nees S, Widenfalk J, Punga AR. The impact of physical exercise on neuromuscular function in Myasthenia gravis patients: A single-subject design study. Medicine (Baltimore). 2018;97(31):e11510. Publication link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6081147/
  6. Wang S, Breskovska I, Gandhy S, Punga AR, Guptill JT, Kaminski HJ. Advances in autoimmune myasthenia gravis management. Expert Rev Neurother. 2018;18(7):573-588.
  7. Sabre L, Maddison P, Sadalage G, Ambrose PA, Punga AR. Circulating microRNA miR-21-5p, miR-150-5p and miR-30e-5p correlate with clinical status in late onset myasthenia gravis. J Neuroimmunol. 2018;321:164-170. Publication link: https://www.jni-journal.com/article/S0165-5728(18)30122-X/fulltext
  8. Molin CJ, Sabre L, MD, Weis CA, Punga T, Punga AR. Thymectomy lowers the myasthenia gravis biomarker miR-150-5p. Neurology: Neuroimmunology and Neuroinflammation, 2018;5(3):e450. Publication link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833334/
  9. Molin CJ, Widenfalk J, Punga AR. High-resistance strength training does not affect nerve cross sectional area – An ultrasound study. J Clin Neurophys Pract, 2017;2: 163-169. Publication link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6123855/
  10. Amandusson Å, Elf K, Grindlund ME, Punga AR. Diagnostic Utility of Repetitive Nerve Stimulation in a Large Cohort of Patients With Myasthenia Gravis. J ClinNeurophysiol. 2017;34(5):400-407.
  11. Sabre L, Westerberg E, Liik M, Punga AR. Diversity in mental fatigue and social profile of patients with myasthenia gravis in two different Northern European countries. Brain Behav. 2017;7(4):e00653. Publication link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5390836/
  12. Molin CJ, Westerberg E, Punga AR. Profile of upregulated inflammatory proteinsin sera of Myasthenia Gravis patients. Sci Rep. 2017;7:39716. doi:10.1038/srep39716. Publication link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5206650/
  13. Westerberg E, Molin CJ, Lindblad I, Emtner M, Punga AR. Physical exercise in myasthenia gravis is safe and improves neuromuscular parameters and physical performance-based measures: A pilot study. Muscle Nerve. 2017;56(2):207-214.
  14. Liik M, Punga AR. Repetitive nerve stimulation often fails to detect abnormal decrement in acute severe generalized Myasthenia Gravis. Clin Neurophysiol. 2016;127(11):3480-3484.
  15. Punga AR, Alimohammadi M, Fagrell D, Nyberg F, Rees D, Wong C. A Randomized, Comparative Study to Evaluate Efficacy and Safety of Two Injection Volumes of AbobotulinumtoxinA in Treatment of Glabellar Lines. Dermatol Surg. 2016;42(8):967-76. Publication link: https://www.ncbi.nlm.nih.gov/pubmed/27399956
  16. Punga T, Bartoccioni E, Lewandowska M, Damato V, Evoli A, Punga AR. Disease specific enrichment of circulating let-7 family microRNA in MuSK+ myasthenia gravis. J Neuroimmunol. 2016;292:21-6. Publication link: https://www.jni-journal.com/article/S0165-5728(16)30004-2/fulltext
  17. Molin CJ, Punga AR. Compound Motor Action Potential: Electrophysiological Marker for Muscle Training. J Clin Neurophysiol. 2016;33(4):340-5.
  18. Chroni E, Dimisianos N, Punga AR. Low vitamin D levels in healthy controls and patients with autoimmune neuromuscular disorders in Greece. Acta Neurol Belg.2016;116(1):57-63.
  19. Punga AR, Andersson M, Alimohammadi M, Punga T. Disease specific signature of circulating miR-150-5p and miR-21-5p in myasthenia gravis patients. J Neurol Sci.2015;356(1-2):90-6. Publication link: https://www.jns-journal.com/article/S0022-510X(15)00360-3/fulltext
  20.  Punga AR, Eriksson A, Alimohammadi M. Regional diffusion of botulinum toxinin facial muscles: a randomised double-blind study and a consideration for clinical studies with split-face design. Acta Derm Venereol. 2015;95(8):948-51. Publication link: https://www.medicaljournals.se/acta/content/abstract/10.2340/00015555-2093
  21. Phillips WD, Christadoss P, Losen M, Punga AR, Shigemoto K, Verschuuren J, Vincent A. Guidelines for pre-clinical animal and cellular models ofMuSK-myasthenia gravis. Exp Neurol. 2015;270:29-40.
  22. Punga AR, Kaminski HJ, Richman DP, Benatar M. How clinical trials of myasthenia gravis can inform pre-clinical drug development. Exp Neurol. 2015;270:78-81.
  23. Nandedkar SD, Barkhaus PE, Stalberg EV. Cumulative motor index: an index to study progression of amyotrophic lateral sclerosis. J Clin Neurophysiol. 2015;32(1):79-85.
  24. Neuwirth, Barkhaus PE, Burkhardt C, Castro J, Czell D, de Carvalho M, Nandedkar S, Stalberg E, Weber M. Tracking motor neuron loss in a set of six muscles in amyotrophic lateral sclerosis using the Motor Unit Number Index (MUNIX): a 15-month longitudinal multicentre trial. J Neurol Neurosurg Psychiatry. 2015;86(11):1172-9.
  25. Torbergsen T, Jurkat-Rott K, Stalberg EV, Loseth S, Hodneo A, Lehmann-Horn F. Painful cramps and giant myotonic discharges in a family with the Nav1.4-G1306A mutation. Muscle Nerve. 2015;52(4):680-3.
  26. Loseth S, Stalberg EV, Lindal S, Olsen E, Jorde R, Mellgren SI. Small and large fiber neuropathy in those with type 1 and type 2 diabetes: a 5-year follow-up study. Journal of the peripheral nervous system : JPNS. 2016;21(1):15-21.
  27. Marrero HG, Stalberg EV. Optimizing testing methods and collection of reference data for differentiating critical illness polyneuropathy from critical illness MYOPATHIES. Muscle Nerve. 2016;53(4):555-63.
  28. Stalberg E. Between genetics and biology. Is ENMG useful in peripheral neuropathy diagnosis and management? Rev Neurol (Paris). 2016;172(10):627-31.
  29. Stalberg E, Sanders DB, Ali S, Cooray G, Leonardis L, Loseth S, et al. Reference values for jitter recorded by concentric needle electrodes in healthy controls: A multicenter study. Muscle Nerve. 2016;53(3):351-62.
  30. Neuwirth C, Barkhaus PE, Burkhardt C, Castro J, Czell D, de Carvalho M, Nandedkar S, Stalberg E Weber M. Motor Unit Number Index (MUNIX) detects motor neuron loss in pre-symptomatic muscles in Amyotrophic Lateral Sclerosis. Clin Neurophysiol. 2017;128(3):495-500.
  31. Feresiadou A, Casar-Borota O, Dragomir A, Oldfors CH, Stalberg E, Oldfors A. Tubular aggregates in congenital myasthenic syndrome. Neuromuscul Disord. 2017. 10.1016/j.nmd.2017.11.009


Publikationer 2015-2018

  1. Backman S, Rosén I, Blennow M, Andersson T, Englund M, Flink R, Hallberg B, Liedholm LJ, Norman E, Sailer A, Thordstein M. Swedish consensus reached on recording, interpretation and reporting of neonatal continuous simplified
    electroencephalography that is supported by amplitude-integrated trend analysis.
    Acta Paediatr. 2018 Oct;107(10):1702-1709.
  2. Bjellvi J, Timby N, Flink R. [Status epilepticus in children and adults].
    Lakartidningen. 2018 May 22;115. pii: E4XY. Swedish. PubMed PMID: 29786808.
  3. Jensson D, Enghag S, Bylund N, Jonsson L, Wikström J, Grindlund M, Flink R,Rodriguez-Lorenzo A. Cranial Nerve Coactivation and Implication for Nerve Transfers to the Facial Nerve. Plast Reconstr Surg. 2018 Apr;141(4):582e-585e.
  4. Edelvik A, Flink R, Malmgren K: Prospective and longitudinal long-term employment outcomes after resective epilepsy surgery. Neurology, 2015 on line publication 10.1212/WNL.0000000000002069
  5. Nilsson DT, Rydenhag B, Flink R, Malmgren K: Outcomes of multilobar resections for focal epilepsy in Sweden 1990-2013 - a national population-based study. Acta Neurochirurgica, DOI 10.1007/s++701-016-2807-3, 2016.
  6. Ambrus GG, Chaieb L, Stilling R, Rothkegel H, Antal A, Paulus W. Monitoring transcranial direct current stimulation induced changes in cortical excitability during the serial reaction time task. Neurosci Lett. 2016 Mar 11;616:98-104. doi: 10.1016/j.neulet.2016.01.039.
  7. Jensson D, Enghag S, Flink R, Grindlund  M, Jonsson L, Rodriquez A:Cranial Nerve Co-activation and Implication for Nerve Transfers to the Facial Nerve. Plastic and Reconstructive Surgery, 2017.
  8. Halawa I, Vlachogiannis P, Amandusson Å, Elf K, Engström ER, Zetterberg H, Kumlien E. Seizures, CSF neurofilament light and tau in patients with subarachnoid haemorrhage. Acta Neurol Scand. 2017 Nov 21. doi: 10.1111/ane.12873.
  9. Amandusson Å, Flink R, Axelson HW. Comparison between adaptive and fixed stimulus paired-pulse transcranial magnetic stimulation (ppTMS) in normal subjects. Clinical Neurophysiology Practice. 2017 (2):91-97
  10. Jansson D, Medvedev A, Axelson H, Nyholm D. Stochastic anomaly detection in eye-tracking data for quantification of motor symptoms in Parkinson´s disease. 2015. In: Signal and Image Analysis for Biomedical and Life Sciences (pp.63-82). Springer.